Stay updated on Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Sign up to get notified when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.

Latest updates to the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page
- Check6 days agoChange DetectedRevision label updated to v3.5.0. The previous revision label v3.4.3 has been removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 on the page.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing v3.4.1 as the current revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedThe revision label changed from v3.4.0 to v3.4.1. This appears to be a minor version update with no evident changes to page content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page shows a new revision label: Revision: v3.3.4 replacing the previous v3.3.3. There are no visible changes to study details, content, or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check92 days agoChange DetectedLocations section reorganized and expanded: per-state and per-country site headers were replaced with a consolidated Locations list, adding numerous new sites across the US, Australia, India, Israel, and Europe.SummaryDifference2%

Stay in the know with updates to Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.